.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Julphar
Medtronic
Queensland Health
McKesson
Accenture
Chubb
Chinese Patent Office
McKinsey
Cerilliant

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018565

« Back to Dashboard

NDA 018565 describes INFUMORPH, which is a drug marketed by West-ward Pharms Int and is included in one NDA. It is available from one supplier. Additional details are available on the INFUMORPH profile page.

The generic ingredient in INFUMORPH is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for 018565

Tradename:2
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 018565

Mechanism of ActionFull Opioid Agonists

Medical Subject Heading (MeSH) Categories for 018565

Suppliers and Packaging for NDA: 018565

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DURAMORPH PF morphine sulfate INJECTABLE;INJECTION 018565 NDA West-Ward Pharmaceuticals Corp. 0641-6019 0641-6019-10 10 AMPULE in 1 CARTON (0641-6019-10) > 10 mL in 1 AMPULE (0641-6019-01)
DURAMORPH PF morphine sulfate INJECTABLE;INJECTION 018565 NDA West-Ward Pharmaceuticals Corp. 0641-6020 0641-6020-10 10 AMPULE in 1 CARTON (0641-6020-10) > 10 mL in 1 AMPULE (0641-6020-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.5MG/ML
Approval Date:Sep 18, 1984TE:APRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Sep 18, 1984TE:APRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Jul 19, 1991TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Fish and Richardson
Accenture
Baxter
Chubb
McKesson
Fuji
Teva
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot